Canada Pension Plan Investment Board
FATE icon

Canada Pension Plan Investment Board’s Fate Therapeutics FATE Stock Holding History

Canada Pension Plan Investment Board’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-132,700
Closed -$435K – 1380
2024
Q2 		$435K Hold
132,700
– – ﹤0.01% 1069
2024
Q1 		$974K Buy
+132,700
New +$821K ﹤0.01% 1037
2022
Q4 		– Sell
-7,224
Closed -$162K – 1198
2022
Q3 		$162K Buy
7,224
+600
+9% +$17.3K ﹤0.01% 1049
2022
Q2 		$164K Buy
6,624
+800
+14% +$22.1K ﹤0.01% 1098
2022
Q1 		$226K Buy
5,824
+3,830
+192% +$148K ﹤0.01% 1076
2021
Q4 		$117K Buy
1,994
+1,699
+576% +$96.3K ﹤0.01% 1322
2021
Q3 		$17K Buy
+295
New +$23.1K ﹤0.01% 1327
2018
Q3 		– Sell
-80,000
Closed -$907K – 1281
2018
Q2 		$907K Buy
+80,000
New +$881K ﹤0.01% 1070

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Canada Pension Plan Investment Board's FATE Position: Q3 2024 in Review

Canada Pension Plan Investment Board sold out of Fate Therapeutics (FATE) in Q3 2024, closing a stake of 132,700 shares — an estimated $435K sold.

Canada Pension Plan Investment Board first reported a position in FATE in Q2 2018 and held it in 8 quarters. The position peaked at $974K in Q1 2024. 164 funds tracked by Wall St. Rank hold FATE as of Q3 2024.

  • Canada Pension Plan Investment Board reported no remaining Fate Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 132,700 Fate Therapeutics shares in Q3 2024, an estimated $435K.
  • Canada Pension Plan Investment Board first reported a position in Fate Therapeutics in Q2 2018 and held it in 8 quarters.
  • Canada Pension Plan Investment Board's Fate Therapeutics position peaked at $974K in Q1 2024.
  • 164 funds tracked by Wall St. Rank held Fate Therapeutics as of Q3 2024.

Based on Canada Pension Plan Investment Board's 13F filing for Q3 2024, filed 14 Nov 2024.